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1 These authors equally contributed to this work.Interaction between adipocytes and macrophages contributes to the development of insulin resis-
tance in obese adipose tissues. In this study, we examined whether luteolin, food-derived ﬂavonoid,
could suppress the production of inﬂammatory mediators of the interaction between adipocytes
and macrophages. Experiments using a coculture system of adipocytes and macrophages showed
that luteolin suppressed the production of inﬂammatory mediators. In addition, activated macro-
phages were targets for the suppressive effect of luteolin. Luteolin inhibited the phosphorylation
of JNK and suppressed the production of inﬂammatory mediators in the activated macrophages.
The ﬁndings indicate that luteolin can inhibit the interaction between adipocytes and macrophages
to suppress the production of inﬂammatory mediators, suggesting that luteolin is a valuable food-
derived compound for the treatment of metabolic syndrome.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Obesity is often accompanied by hyperglycemia, hypertension,
and hyperlipidemia, which together are called metabolic syndrome
[1]. Recent studies have elucidated that obesity is characterized by
low-grade chronic inﬂammation of adipose tissues and that such
inﬂammation is one of the potential mechanisms underlying insu-
lin resistance [2–4]. It has been indicated that adipose tissues con-
tain various cells in addition to adipocytes, in which there are
paracrine interactions between adipocytes and such non-adipo-
cytes. Inﬁltration of macrophages is observed in obese adipose tis-
sues [5,6]. The inﬁltrating macrophages are crucial contributors to
the interactions to induce inﬂammation of obese adipose tissues.
Generally, the nuclear factor-jB (NF-jB) pathway and mitogen-
activated protein kinase (MAPK) pathway play indispensable roles
in inﬂammation [7]. In obese adipose tissues, both pathways are
involved in the production of inﬂammatory mediators from the
activated macrophages and/or adipocytes [8,9]. Thus, the degrada-
tion of I-jB and activation of MAPK are valuable markers for the
detection of inﬂammation of adipose tissues.chemical Societies. Published by E
.Suganami and colleagues have reported that adipocyte-derived
free fatty acid (FFA), monocyte chemoattractant protein (MCP)-1,
and macrophage-derived tumor necrosis factor-a (TNFa) establish
a vicious cycle enhancing inﬂammation and leading to insulin
resistance in obese adipose tissue [8,9]. Matured adipocyte-derived
MCP-1 enhances the inﬁltration of macrophages, which are acti-
vated by adipocyte-derived FFA to stimulate the release of TNFa
from the inﬁltrating macrophages. The released TNFa in turn stim-
ulates lipolysis in adipocytes to induce overproduction of FFA.
Therefore, anti-inﬂammatory compounds that suppress such an
inﬂammatory vicious cycle may contribute to the reduction of
obesity-related insulin resistance.
Foods contain various bioactive compounds. Among them,
ﬂavonoids are considered to be particularly valuable compounds,
with multifunction including antioxidative, anticancer, and anti-
inﬂammatory effects [10–12]. Luteolin is a food-derived ﬂavonoid,
which is present in medicinal plants and in some vegetables and
spices. Luteolin exhibits speciﬁc anti-inﬂammatory effects at
micromolar concentrations, which are only partly explained by
its antioxidant capacities. A recent review has provided the phar-
macological data on the antioxidant, anti-inﬂammatory, and
antiallergy functions of luteolin [12]. However, the effects of lute-
olin on low-grade chronic inﬂammation of obese adipose tissues
remain to be clariﬁed. Thus, the purpose of this study is to examinelsevier B.V. All rights reserved.
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40
3650 C. Ando et al. / FEBS Letters 583 (2009) 3649–3654the anti-inﬂammatory effects of luteolin on the interaction be-
tween adipocytes and macrophages to elucidate whether luteolin
is effective for reducing inﬂammation in obese adipose tissues.B
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Fig. 1. Luteolin inhibited inﬂammation in contact coculture system. Protein
secretion levels of inﬂammatory mediators, TNFa (A) and MCP-1 (B), and release
of NO (C). Luteolin was added to the contact coculture system of RAW264
macrophages and 3T3-L1 adipocytes. After 24 h, TNFa and MCP-1 secretion levels in
the cultured medium were measured by ELISA. The secretion level of NO was
measured using Griess reagent. The values are mean ± S.E.M. of 3–4 tests. *P < 0.05
and **P < 0.01 compared with a vehicle control.2. Materials and methods
2.1. Chemicals and cell cultures
Luteolin was purchased from Wako Chemicals (Osaka, Japan)
and dissolved in DMSO to prepare a stock solution. All other chem-
icals were purchased from Sigma (MO, USA) and Nacalai Tesque
(Kyoto, Japan).
A RAW264 macrophage cell line (RIKEN BioResource Center,
Tsukuba, Japan) was cultured in DMEM with 10% fetal bovine ser-
um (FBS), 100 U/ml penicillin, and 100 lg/ml streptomycin (Gibco
BRL, NY, USA) at 37 C under a humidiﬁed 5% CO2 atmosphere as
previously described [13–15]. The serum-free medium of
RAW264 macrophages cultured for 24 h was collected as a
RAW264 conditioned medium and stored at 20 C until use.
The cells were seeded in 12-well plates (5  105 cells/ml) and trea-
ted with various concentrations of luteolin in serum-free medium
for 24 h.
3T3-L1 preadipocytes (American Type Culture Collection, VA,
USA) were subcultured in DMEM with 10% FBS, 100 U/ml penicil-
lin, and 100 lg/ml streptomycin at 37 C under a humidiﬁed 5%
CO2 atmosphere. Differentiation of 3T3-L1 preadipocytes was in-
duced by treatment with adipogenic agents (0.5 mM 3-isobutyl-
1-methylxanthine, 0.25 lM dexamethasone, and 10 lg/ml insulin)
in DMEM containing 10% FBS for 2 days after the cells reached con-
ﬂuence (day 0), as previously described [13,14]. Then, the medium
was replaced with DMEM containing 10% FBS and 5 lg/ml insulin
and was replaced every 2 days. Twenty days after the differentia-
tion induction, the cells that accumulated large lipid droplets were
used as hypertrophied 3T3-L1 adipocytes. The serum-free medium
of hypertrophied 3T3-L1 adipocytes cultured for 12 h was collected
as a 3T3-L1 conditioned medium and stored at 20 C until use.
RAW264 cells were seeded in 96-well plates and treated with var-
ious concentrations of luteolin for 24 h. The viability of RAW264
macrophages was measured by CellTiter 96 AQueous One Solution
Cell Proliferation Assay (Promega, MO, USA). 3T3-L1 cells were
seeded in 96-well plates and induced to differentiate in DMEM
containing various concentrations of luteolin. The medium was re-
placed every 2 days and cell viability was measured in the same
procedure.
2.2. Stimulation of macrophages and adipocytes
Adipocytes and macrophages were cocultured in a contact sys-
tem, as previously described [14,15]. Brieﬂy, RAW264 cells
(1  105 cells/ml) were plated onto dishes with serum-starved
and hypertrophied 3T3-L1 cells, and the coculture was incubated
in serum-free DMEM for 24 h. RAW264 and 3T3-L1 cells of equal
concentrations to those in the coculture were cultured separately
as control cultures. Luteolin was added to the coculture at various
concentrations, as described in each ﬁgure legend. After 24 h of
treatment, culture supernatants were collected and stored at
20 C until use.
2.3. Measurement of inﬂammatory mediators
The concentrations of TNFa and MCP-1 in the culture superna-
tants were determined by ELISA, which was conducted using
Ready-Set-Go Mouse TNFa and MCP-1 kits (eBioscience, CA,
USA), in according with the manufacturer’s protocols. NO release
was measured using Griess reagent, as described previously[14,15]. Brieﬂy, 100 ll of supernatant was mixed with an equiva-
lent volume of Griess reagent [1:1 (v/v) of 0.1% N-1-naphthyl-eth-
ylenediamine in distilled water and 1% sulfanilamide in 5%
phosphoric acid] on 96-well ﬂat-bottom plates. After 10 min, the
absorbance at 570 nm was measured and the amount of nitrite
was calculated from the NaNO2 standard curve.
Total RNA preparation and quantiﬁcation of gene expression
were performed as previously described [13,14]. The cells were
washed with PBS and total RNA was prepared using Sepasol
(R)-RNA Super (Nacalai Tesque) in according with the manufac-
turer’s protocol. Aliquots of total RNA were reverse-transcribed
using M-MLV reverse transcriptase (Invitrogen Corp., CA, USA)
and a thermal cycler (Takara PCR Thermal Cycler SP: Takara Shu-
zo Co., Kyoto, Japan). To quantify mRNA expression, real-time RT-
PCR was performed with a LightCycler System (Roche Diagnostics,
Mannheim, Germany) using SYBR Green ﬂuorescence signals. The
oligonucleotide primers of inﬂammatory mediator genes were
designed using a PCR primer selection program shown on the
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Fig. 2. Luteolin did not suppress adipocyte inﬂammation induced by macrophage-derived conditioned medium. Protein secretion and mRNA expression levels of TNFa (A, B)
and MCP-1 (C, D). Hypertrophied 3T3-L1 adipocytes were incubated with the conditioned medium of RAW264 macrophages and various concentrations of luteolin for 24 h.
The TNFa and MCP-1 secretions in the cultured medium were measured by ELISA. The mRNA expression levels of these mediators were measured by real-time RT-PCR. The
values are mean ± S.E.M. of 3–4 tests.
C. Ando et al. / FEBS Letters 583 (2009) 3649–3654 3651website of the Virtual Genomic Center from the GenBank data-
base. All PCR primers were previously described [13,14]. To com-
pare mRNA expression levels among the samples, the copy
numbers of all transcripts were divided by that of mouse 36B4
showing a constant expression level. All mRNA expression levels
are presented as a ratio relative to that of a control in each
experiment.
2.4. Western blotting
Western blotting was performed as previously described
[14,16]. In brief, RAW264 cells were washed with PBS and placed
immediately in lysis buffer containing 20 mM Tris–HCl (pH 7.5),
15 mM NaCl, 1% Triton X-100 (Nacalai Tesque), and a protease
inhibitor cocktail (Nacalai Tesque). The lysate was centrifuged at
15 000 rpm for 5 min, and the supernatant was stored for subse-
quent analysis. Protein concentration was determined using DC
protein assay reagents (BioRad Laboratories, CA, USA) in accor-
dance with the method of Lowry et al. [21]. Fifteen micrograms
of protein was separated by 10% SDS–PAGE, and transferred to an
Immobilon-P membrane (Millipore, MA, USA). After blocking, the
membrane was incubated with an anti-I-jB-a (Santa Cruz Biotech-
nology, CA, USA), anti-JNK (Cell Signaling Technology, MA, USA),
anti-pJNK (Cell Signaling Technology), or b-actin (Cell Signaling
Technology) antibody, and then with a secondary antibody conju-
gated to horseradish peroxidase [anti-rabbit IgG: 1/2000 (Promega,
WC, USA) ] for 1 h. The secondary antibody staining was visualized
by chemiluminescence immunoassay using a chemiluminescent
HRP substrate (Millipore).
2.5. Statistical analyses
The data are presented as mean ± S.E.M. and were statistically
analyzed using one-way ANOVA when their variances were heter-
ogeneous and unpaired t-test. Differences were considered signiﬁ-
cant at P < 0.05.3. Results
3.1. Effects of luteolin on inﬂammation in coculture of adipocytes and
macrophages
To examine the effects of luteolin on the interaction between
adipocytes and macrophages, we used a coculture system using
3T3-L1 adipocytes and RAW264 macrophages, in which these
cells were in direct contact. The coculture revealed marked
increases in secretion levels of inﬂammatory mediators such as
TNFa, MCP-1, and NO (Fig. 1A–C). Treatment with luteolin in
the coculture system signiﬁcantly decreased the secretion levels
of the inﬂammatory mediators in a dose-dependent manner. In
particular, the secretion of TNFa was markedly suppressed to a
control level at a higher concentration of luteolin (20 lM). The
concentrations of luteolin used in this experiment did not
affect the viability of either RAW264 or 3T3-L1 cells (data not
shown). These results indicate that luteolin has anti-inﬂamma-
tory effects in the contact coculture system of adipocytes and
macrophages.
3.2. Effects of luteolin on macrophage activation induced by adipocyte-
derived conditioned medium
Next, to clarify the anti-inﬂammatory effects of luteolin, we
conducted medium change experiments. First, to examine the ef-
fect of luteolin on 3T3-L1 adipocytes, a conditioned medium of
RAW264 macrophages was added to a hypertrophied 3T3-L1 adi-
pocyte culture. The addition of the RAW264 conditioned medium
signiﬁcantly increased the levels of TNFa and MCP-1 protein secre-
tion from 3T3-L1 cells (Fig. 2A and C). mRNA expression levels of
the mediators were also increased by the RAW264 conditioned
medium (Fig. 2B and D). However, the treatment with luteolin
did not suppress the TNFa and MCP-1 expression at both protein
secretion and mRNA expression levels. Thus, these results indicate
that 3T3-L1 adipocytes are not a target of luteolin.
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Fig. 3. Luteolin suppressed macrophage activation induced by adipocyte-derived conditioned medium. RAW264 macrophages were incubated with the conditioned medium
derived from the hypertrophied 3T3-L1 adipocytes (L1 medium) and various concentrations of luteolin for 24 h. The TNFa (A) and MCP-1 (C) protein levels were measured by
ELISA. The secretion level of NO (E) was also measured using Griess reagent. The mRNA expression levels of TNFa (B), MCP-1 (D), and iNOS (F) were measured by real-time RT-
PCR. The values are mean ± S.E.M. of 3–4 tests. *P < 0.05 and **P < 0.01 compared with a vehicle control.
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on RAW264 macrophages, a conditioned medium of hypertrophied
3T3-L1 adipocytes was added to a RAW264 macrophage culture.
The addition of the 3T3-L1 conditioned medium increased the level
of TNFa secretion from RAW264 macrophages (Fig. 3A). Treatment
with luteolin signiﬁcantly decreased TNFa secretion level in a
dose-dependent manner. The treatment with luteolin also sup-
pressed TNFa mRNA expression (Fig. 3B). In addition to TNFa,
the levels of secretion of MCP-1 and release of NO from RAW264
macrophages were increased by the 3T3-L1 conditioned medium
(Fig. 3C and E). The increase was reduced to a control level by
20 lM luteolin (Fig. 3C and E). The addition of luteolin also signif-
icantly decreased the mRNA expression levels of MCP-1 and induc-
ible-NO synthase (iNOS) (Fig. 3D and F). These anti-inﬂammatory
effects of luteolin were observed in LPS-stimulated productions
of inﬂammatory mediators. LPS (5 lg/ml) resulted in 414-, 15.1-,
and 9.37-fold increases in productions of TNFa, MCP-1, and NO,
respectively, in RAW264 macrophages. Luteolin (10 lM) inhibited
the LPS-dependent productions in TNFa, MCP-1, and NO at 66.5%,
38.2%, and 56.2%, respectively. These effects of luteolin on the
LPS-induced inﬂammation were a dose-dependent manner (data
not shown). These results indicate that luteolin has anti-inﬂamma-
tory effects on macrophages in terms of the interaction between
adipocytes and macrophages.3.3. Effects of luteolin on degradation of I-jB and activation of MAPK
NF-jB is one of the major transcription factors that regulate the
induction of various inﬂammatory mediators including TNFa,
MCP-1, and iNOS [7]. To clarify the molecular mechanism underly-
ing the anti-inﬂammatory effects of luteolin, we investigated
whether luteolin inhibits I-jB degradation, which activates NF-
jB, in RAW264 macrophages. I-jB degradation was observed in
RAW264 macrophages stimulated by the 3T3-L1 adipocyte-de-
rived conditioned medium (Fig. 4A). However, the pretreatment
with luteolin did not inhibit the degradation of I-jB. These results
show that luteolin has no effect on I-jB degradation in RAW264
macrophages stimulated by the 3T3-L1 adipocyte-derived condi-
tioned medium, although the conditioned medium promoted the
degradation of I-jB.
Next, we examined the effects of luteolin on the MAPK path-
way. To determine which MAPK subtypes regulate the production
of the inﬂammatory mediators, we used three different MAPK
inhibitors to block the activation of each MAPK. A speciﬁc JNK
inhibitor, SP600125 (10 lM), signiﬁcantly inhibited the production
of all the inﬂammatory mediators (Fig. 4B). However, an ERK inhib-
itor, PD98059 (10 lM), or a p38 inhibitor, SB239063 (10 lM), only
partially inhibited the production. These results indicate that JNK
regulates the production of all inﬂammatory mediators examined
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adipocytes.
Finally, we investigated the effects of luteolin on the JNK activa-
tion. The stimulation of RAW264 with the 3T3-L1 adipocyte-de-
rived conditioned medium resulted in an enhanced
phosphorylation of JNK (Fig. 4C). The pretreatment of RAW264
macrophages with 5 and 20 lM luteolin inhibited JNK phosphory-
lation. These results indicate that luteolin inhibits the activation of
JNK to suppress the inﬂammatory mediators in the contact cocul-
ture system, suggesting that a target of the anti-inﬂammatory ef-
fects of luteolin is the MAPK pathway in activated macrophages.
4. Discussion
In this study, luteolin suppressed the production of proinﬂam-
matory mediators such as TNFa, MCP-1, and NO in a coculture
system using 3T3-L1 adipocytes and RAW264 macrophages.
Many reports have indicated that obesity is related to obese adi-
pose tissue inﬂammation, which causes insulin resistance in the
liver and adipose tissues [7,22–24]. Although the causes of
inﬂammation related to obesity have not been completely eluci-
dated, macrophages in ﬁltrating into obese adipose tissues seem
to play an indispensable role in the inﬂammation [5,6]. Macro-
phages inﬁltrate into obese adipose tissues as induced by MCP-
1 and then by FFA, both of which are derived from matured adi-
pocytes. The inﬁltrating and activated macrophages in adipose
tissues secrete TNFa to induce additional secretion of MCP-1
and FFA from the matured adipocytes. The cytokine paracrine
loop establishes a vicious cycle that aggravates the inﬂammation
and insulin resistance in obese adipose tissues [8,9]. Thus, block-
ade of this loop is an important target for the treatment of adi-
pose tissue inﬂammation and insulin resistance. Several studies
have already shown that luteolin has anti-inﬂammatory effectson LPS-activated macrophages [25]. However, it was unclear
whether luteolin can suppress the vicious cycle in adipose tissues
to improve insulin resistance. Thus, we have examined the anti-
inﬂammatory effects of luteolin on the interaction between adi-
pocytes and macrophages. Our used concentrations were 0.1–
20 lM, which is consistent to the previous studies (3–25 lM).
These concentrations were used to LPS-stimulated macrophages
in the previous studies. Luteolin showed more effective in our
coculture experiments than in the LPS-used ones. This might be
because the coculture system is weaker than the LPS system in
term of the macrophage activation. Moreover, in our ﬁndings,
the anti-inﬂammatory effects of luteolin were more effective in
the coculture system than the adipocyte-derived conditioned
medium (Figs. 1 and 3). This is because luteolin also suppressed
lipolysis in 3T3-L1 adipocytes, which causes additional activation
in the coculture system (data not shown), although we should
perform further investigation of luteolin’s effects in adipocytes.
The results in this study indicate that luteolin inhibits the pro-
duction of proinﬂammatory mediators from macrophages, sug-
gesting a possibility that luteolin is a valuable food-derived
compound for improving inﬂammation-related insulin resistance.
However, to elucidate whether luteolin can block the cytokine
paracrine loop in obese adipose tissues, animal experiments using
high fat diet-fed mice are indispensable in the future.
In the LPS-induced inﬂammation, the Toll-like receptor-4 (TLR-
4) signaling pathway is very important, as it activates both NF-jB
and MAPK pathways [26,27]. LPS binds to and activates TLR-4 to
induce NF-jB- and AP-1-dependent transcription through I-jB
degradation and MAP kinase activation, respectively. NF-jB and
AP-1 coordinately stimulate mRNA induction of inﬂammatory
mediators including TNFa, MCP-1, and iNOS. Thus, both transcrip-
tional factors are indispensable for the production of proinﬂamma-
tory mediators. In this study, luteolin inhibited the JNK activation
3654 C. Ando et al. / FEBS Letters 583 (2009) 3649–3654but not I-jB degradation in the activated macrophages. The results
are consistent with those of a previous study using LPS-stimulated
microglia, in which IL-6 production was suppressed by luteolin
through inhibition of JNK activation not I-jB degradation [28].
Moreover, it has been reported that JNK plays a signiﬁcant role of
the productions of inﬂammatory mediators in the coculture system
[8,9]. Although there is a possibility that other MAP kinases (p38
and ERK) are involved in the mechanism underlying the anti-
inﬂammatory effect of luteolin, the inhibition of JNK activation
seems to be a particular target of the anti-inﬂammatory effects
of luteolin. This is because only inhibition of JNK could suppress
the release of all inﬂammatory mediators derived from the acti-
vated macrophages.
Various naturally occurring compounds exhibit positive effects
on metabolic syndrome. We have already reported several food-
derived factors that attenuate insulin resistance, obesity, and ath-
erosclerosis [13–20]. For example, abietic acid and dehydroabietic
acid (a derivative of abietic acid) exhibit anti-inﬂammatory effects
similar to those of luteolin [13,15], although the mechanism
underlying the effects is completely different from that of luteolin.
Abietic acid and dehydroabietic acid serve as agonists of peroxi-
some proliferator-activated receptor-c (PPARc), which shows
anti-inﬂammatory effects through its activation in macrophages
[13,15]. Luteolin did not serve as the agonist in a luciferase repor-
ter assay (data not shown). Recently, it has been reported that a
combination of bioactive compounds is very effective in vivo
[29]. In particular, a combination of compounds exhibiting differ-
ent mechanisms by which anti-inﬂammatory effects are exerted
seems to be most efﬁcient. Therefore, luteolin may be suitable
for the treatment of metabolic syndrome with PPARc agonists such
as abietic acid and dehydroabietic acid, although additional exper-
iments are required.
In conclusion, luteolin, a food-derived ﬂavonoid, suppressed the
production of proinﬂammatory mediators such as TNFa, MCP-1,
and NO from macrophages in a coculture system using 3T3-L1 adi-
pocytes and RAW264 macrophages. In addition, the target of lute-
olin was macrophages not adipocytes, because luteolin inhibited
the production of proinﬂammatory mediators from only the mac-
rophages activated by the adipocyte-derived conditioned medium.
In the activated macrophages, luteolin inhibited JNK activation to
suppress mRNA expression of the mediators. The results indicate
that luteolin suppresses the adipocyte-dependent activation of
macrophages, suggesting a possibility that luteolin attenuates
insulin resistance in obese adipose tissues with low-grade chronic
inﬂammation.
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